NCT07011342View on ClinicalTrials.gov

Utility of 18F-rhPSMA-7.3 in the Diagnosis of Prostate Cancer After Focal Gland Treatment

NARecruitingINTERVENTIONAL

Enrollment

70

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

November 30, 2028

Study Completion Date

November 30, 2028

Conditions

Prostate Cancer

Interventions

DRUG

18F-rhPSMA-7.3

Utility of 18F-rhPSMA-7.3 in the diagnosis of prostate cancer after Focal Gland Treatment (SCOUT)

Trial Locations (1)

07601

RECRUITING

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack

Sponsors

Collaborators (1)

Blue Earth Diagnositcs

All Listed Sponsors

collaborator

Blue Earth Diagnositcs

UNKNOWN

lead

Hackensack Meridian Health

OTHER